Benefits over ban of duplicate prescriptions of same ingredient are minimal

The government plans to discourage the reissued prescriptions of same ingredient in fear that it will not be help to helpful to the budget for national health insurance, but such measure is not deemed economical, according to a report released by Samsung Medical Center in Seoul.

In an one-year survey of 17,868 outpatients who made their visits to the hospital last year, the medication charge...